Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

In the brightly lit corridors of a Nigerian hospital, an unspoken fear lingers, not just among patients, but among the very ...

U.S. funded treatments in the country have helped reduce deaths from HIV/AIDS to around 14,000 a year, from as high as ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...

Ending USAID could lead to the deaths of 14 million people over the next five years, an analysis from a medical journal predicts.

As science soars with game-changing HIV tools, a funding crisis threatens to ground progress "We come together at a pivotal time for the HIV response, one defined by both incredible scientific ...

As Uganda grapples with a resurgence of new HIV infections, we must confront the uncomfortable truth: complacency is our greatest enemy. According to an Economic Policy Research Centre ( EPRC) report ...

IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global funding challenges. Four ...

The threat of HIV looms large over Punjab, darker than ever before. While the disease itself is more treatable now than ever before, the stigma and misconception surrounding the virus make countering ...

One way to cope with cuts in HIV prevention funding is to continue to push to increase the number of people who self-test for HIV instead of getting tested at a clinic or hospital, experts at a series ...

In the mid-nineties, a friend of mine told me that he lost 30 friends and acquaintances to HIV/AIDS in just one week. It was a miracle that he was still alive. Although cases have decreased ...